Tobacco: An atherogenic, thrombogenic or spasmogenic factor?;Tabac: Fateur atherogene, thrombogene ou spasmogene?

Archives des Maladies du Coeur et des Vaisseaux

Volumn 91, Issue SPEC. ISS. 5, 1998, Pages 53-58

  Adnot, S ^a  

^a HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; CATECHOLAMINE; LIPID; NICOTINE; OXYGEN;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL TONE; CORONARY ARTERY SPASM; HEART INFARCTION; HEART MUSCLE OXYGEN CONSUMPTION; HEART WORK; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; INFLAMMATORY CELL; OXYGEN TRANSPORT; SMOKING; THROMBOGENESIS; TOBACCO; VASCULAR ENDOTHELIUM; ARTERIOSCLEROSIS; CAUSE OF DEATH; CHEMICALLY INDUCED DISORDER; MORTALITY; OXIDATIVE STRESS; PLANT; REVIEW; RISK FACTOR; THROMBOSIS;

ARTERIOSCLEROSIS; CARBON MONOXIDE; CAUSE OF DEATH; HUMANS; MYOCARDIAL INFARCTION; OXIDATIVE STRESS; PLANTS, TOXIC; RISK FACTORS; SMOKING; THROMBOSIS; TOBACCO;

EID: 0031783072     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Wilhelmsen L. Coronary heart disease : epidemiology of smoking and interventions studies of smoking. Am Heart J 1988 ; 5 : 242-9.
2. Khan AH, Haywood LJ. Myocardial infarction in nine patients with radiologically patent coronary arteries. N Engl J Med 1974 ; 291 : 427-31.
3. Grines CL, Topol EJ, O'Neill WW. Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarction. Circulation 1995 ; 91 : 298-303.
4. Rivers JT, White HD, Cross DB, Williams B, Norris RM. Reinfarction after thrombolytic therapy for acute myocardial infarction followed by conservative management incidence and effect of smoking. J Am Coll Cardiol 1990 ; 16 : 340-8.
5. Cryer PE, Haymond MW, Santiago JV, Shah SD. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med 1976 ; 295 : 573-7.
6. Kool MJF, Hoeks APG, Strüijker Boudier HAJ, Reneman RS, Van Bortel LMAB. Short- and long-term effects of smoking on arterial wall properties in habitual smokers. J Am Coll Cardiol 1993 ; 22 : 1881-6.
7. Benowitz NL, Gourloy SG. Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J Am Coll Cardiol 1997 ; 29 : 1422-31.
8. Green MS, Jucha E, Luz Y. Blood pressure in smokers and nonsmokers : epidemioiogic findings. Am Heart J 1986 ; 111 : 932-40.
9. Pickering T, Schwartz JE, James GD. Ambulatory blood pressure monitoring for evaluating the relationships between lifestyle hypertension and cardiovascular risk. Clin Exp Pharmacol Physiol 1995 ; 22 : 226-31.
10. Alfred EN, Bleecker ER, Chaitman BR. Short-term effects of carbon monoxide exposure on the exercise performance of subjects with coronary artery disease. N Engl J Med 1989 ; 321 : 1426-32.
11. Winniford MD, Wheelan KR, Kremers MS. Smoking-induced coronary vasoconstriction in patients with atherosclerotic coronary artery disease : evidence for adrenergically mediated alterations in coronary artery tone. Circulation 1986 ; 73 : 662-7.
12. Trap-Jensen J. Effects of smoking on the heart and peripheral circulation. Am Heart J 1988 ; 115 : 263-71.
13. Peters RW, Benowitz NL, Valenti S, Modin G, Fisher ML. Electrophysiologic effects of cigarette smoking in patients with and without chronic beta-bloker therapy. Am J Cardiol 1987 ; 60 : 1078-82.
14. Escobedo LG, Zack MM. Comparison of sudden and nonsudden coronary deaths in the United States. Circulation 1996 ; 93 : 2033-6
15. Moliterno DJ, Willard JE, Lange RA et al. Coronary-artery vasoconstriction induced by cocaine, cigarette smoking, or both. N Engl J Med 1994 ; 330 : 454-9.
16. Caralis DG, Ubeydullah D, Kern MJ, Cohen JD. Smoking is a risk factor for coronary spasm in young women. Circulation 1992 ; 85 : 905-9.
17. Klein LW, Ambrose J, Pichards A et al. Acute coronary hemodynamic response to cigarette smoking in patients with coronary artery disease. J Am Coll Cardiol 1984 ; 3 : 879-86.
18. Tell GS, Polak JF, Ward BJ et al. Relation of smoking with carotid artery wall thickness and stenosis in older adults : the cardiovascular health study. Circulation 1994 ; 90 : 2905-8.
19. Howard G, Wagenknecht LE, Burke GL et al. Cigarette smoking and progression of atherosclerosis. JAMA 1998 ; 279 : 119-24.
20. Kimura S, Nishinga M, Ozawa T, Shimada K. Thrombin generation as an acute effect of cigarette smoking. Am Heart J 1994 ; 128 : 7-11.
21. Fitzgerald GA, Dates JA, Nowak J. Cigarette smoking and hemostatic function. Am Heart J 1988 ; 115 : 267-71.
22. Ernst E. Fibrinogen: its emerging role as a cardiovascular risk factor. Angiology 1994 ; 45 : 87-93.
23. Nowak J, Murray JJ, Oates JA, Fitzgerald GA. Biochemical evidence of a chronic anormality in platelet and vascular function in healthy individuals who smoke cigarettes. Circulation 1987 ; 76 : 6-14.
24. Allen RA, Kluft C, Brommer EJP. Effect of chronic smoking on fibrinolysis. Arteriosclerosis 1985 ; 5 : 443-50.
25. Celermajer DS, Sorensen KE, Georggakopoulos D et al. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 1993 ; 88 : 2149-55.
26. Heitzer T, Just H, Munzell T. Antioxidant vitamin C improves endothelial dysfunction in chronic smokers. Circulation 1996 ; 94 : 6-9.
27. Nitenberg A, Antony I, Foult JM. Acetylcholine-induced coronary vasoconstriction in young heavy smokers with normal coronary arteriographic findings. Am J Med 1993 ; 95 : 71-7.
28. Asmussen I, Kjeldsen K. Intimal ultrastructure of human umbilical arteries : observations on arteries from newborn children of smoking and nonsmoking mothers. Circ Res 1975 ; 36 : 579-89.
29. Murohara T, Kugiyama K, Ohgushi M, Sugiyama S, Yasue H. Cigarette smoke extracts contracts isolated porcine coronary arteries by Superoxide anion-mediated degradation of EDRF. Am J Physiol 1994 ; 266 : H 874-H 880.
30. Muscat JE, Harris RE, Haley NJ, Wynder EL. Am Heart J 1991 ; 121 : 141-7.
31. Harats D, Ben-Naim M, Dabach Y et al. Cigarette smoking renders L.D.L susceptible to peroxidative modification and enhanced metabolism by macrophages. Atherosclerosis 1989 ; 79 : 245-52.
32. Stubbe I, Eskilsson J, Nilsson-Ehle P. High-density lipoprotein concentrations increase after stopping smoking. Br Med J 1982 ; 284 : 1511-3.
33. Hellerstein MK, Benowitz NL, Neese RA et al. Effects of cigarette smoking and its cessation on lipid metabolism and energy expenditure in heavy smokers. J Clin Invest 1994 ; 93 : 265-72.
34. Chow CK, Thacker RR, Changchit C. Lower levels of Vit C and carotenes in plasma of cigarette smokers. J Am Coll Nutr 1986 ; 5 : 305-12.
35. Morrow JD, Frei B. Longmire AW. Increase in circulating products of lipid peroxidation (F2 isoprostanes) in smokers. N Engl J Med 1995 ; 332 : 1198-203.
36. Yokode M, Kita T, Arai H et al. Clolesteryl ester accumulation in macrophages incubated with low density lipoprotein pretreated with cigarette smoke extract. Proc Natl Acad Sci 1988 ; 85 : 2344-8.
37. Frei B, Forte TM, Ames BN, Cross CE. Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma. Biochem J 1991 ; 277 : 133-8.
38. Petitti DB, Kipp H. The leucocyte count: associations with intensity of smoking and persistence of effect after quitting. Am J Epidemiol 1986 ; 123 : 89-95.
39. Weber C, Erl W, Weber K, Weber PC. Increased adhesiveness of isolated monocytes to endothelium is prevented by vitamin C intake in smokers. Circulation 1996 ; 93 : 1488-92.
40. Benowitz NL. Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med 1988 ; 19 : 1318-30.
41. Benowitz NL, Fitzgerald GA, Wilson M, Zhang Q. Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking. J Am Coll Cardiol 1993 ; 22 : 1159-67.
42. Anthonisen NR, Connett JE, Kiley JP. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of fev1. JAMA 1994 ; 272 : 1497-505.
43. Joseph AM, Norman SM, Ferry LH. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med 1996 ; 335 : 1792-8.
44. Morita T, Kourmbanas S. Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide. J Clin Invest 1995 ; 96 : 2676-82.
45. Cerami C, Founds H, Nicholl I et al. Tobacco smoke is a source of toxic reactive glycation products. Proc Natl Acad Sci 1997 ; 94 : 13915-20.